Underprescription of beneficial medicines in older people: Causes, consequences and prevention

Drugs and Aging

Volumn 29, Issue 6, 2012, Pages 463-475

  Cherubini, Antonio ^a,b   Corsonello, Andrea ^a   Lattanzio, Fabrizia ^a  

^a INRCA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Drug utilisation; Elderly; Medication errors; Prescribing

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; LAXATIVE; MULTIVITAMIN; NITRATE; NOOTROPIC AGENT; PRESCRIPTION DRUG; SEROTONIN UPTAKE INHIBITOR; VITAMIN D;

AGING; HUMAN; INAPPROPRIATE PRESCRIBING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW;

AGED; DRUG PRESCRIPTIONS; HUMANS; MEDICATION ERRORS;

EID: 84861670972     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/11631750-000000000-00000     Document Type: Review

References (110)

1. Christensen K, Doblhammer G, Rau R, et al. Ageing populations: The challenges ahead. Lancet 2009 Oct 3; 374 (9696): 1196-1208
2. Shi S, Morike K, Klotz U. The clinical implications of ageing for rational drug therapy. Eur J Clin Pharmacol 2008 Feb; 64 (2): 183-199
3. Laroche ML, Charmes JP, Bouthier F, et al. Inappropriate medications in the elderly. Clin Pharmacol Ther 2009 Jan; 85 (1): 94-97
4. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: Implications for pay for performance. JAMA 2005 Aug 10; 294 (6): 716-724
5. Tinetti ME, Bogardus Jr. ST, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 2004 Dec 30; 351 (27): 2870-4
6. Cherubini A, Del Signore S, Ouslander J, et al. Fighting against age discrimination in clinical trials. J Am Geriatr Soc 2010 Sep; 58 (9): 1791-6
7. Cherubini A, Oristrell J, Pla X, et al. The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. Arch Intern Med 2011 Mar 28; 171 (6): 550-6
8. Johnson JA, Bootman JL. Drug-related morbidity and mortality: A cost-of-illness model. Arch Intern Med 1995 Oct 9; 155 (18): 1949-1956
9. Hanlon JT, Schmader KE, Koronkowski MJ, et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc 1997 Aug; 45 (8): 945-8
10. Bootman JL, Harrison DL, Cox E. The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med 1997 Oct 13; 157 (18): 2089-2096
11. Schimmel EM. The hazards of hospitalization. 1964. Qual Saf Health Care 2003 Feb; 12 (1): 58-63; discussion-4
12. Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA 1995 Jul 5; 274 (1): 35-43
13. Cherubini A, Ruggiero C, Gasperini B, et al. The prevention of adverse drug reactions in older subjects. Curr Drug Metab 2011 Sep; 12 (7): 652-7
14. Merle L, Laroche ML, Dantoine T, et al. Predicting and preventing adverse drug reactions in the very old. Drugs Aging 2005; 22 (5): 375-392
15. Hanlon JT, Schmader KE, Ruby CM, et al. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001 Feb; 49 (2): 200-9
16. Corsonello A, Pedone C, Corica F, et al. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med 2005 Apr 11; 165 (7): 790-5
17. Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: Results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002 Dec; 50 (12): 1962-8
18. Olivier P, Bertrand L, Tubery M, et al. Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: A prospective survey. Drugs Aging 2009; 26 (6): 475-482
19. Zopf Y, Rabe C, Neubert A, et al. Risk factors associated with adverse drug reactions following hospital admission: A prospective analysis of 907 patients in two German university hospitals. Drug Saf 2008; 31 (9): 789-798
20. Nguyen JK, Fouts MM, Kotabe SE, et al. Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother 2006 Mar; 4 (1): 36-41
21. Kuijpers MA, Van Marum RJ, Egberts AC, et al. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol 2008 Jan; 65 (1): 130-3
22. Kuzuya M, Masuda Y, Hirakawa Y, et al. Underuse of medications for chronic diseases in the oldest of community-dwelling older frail Japanese. J Am Geriatr Soc 2006 Apr; 54 (4): 598-605
23. Shrank WH, Asch SM, Adams J, et al. The quality of pharmacologic care for adults in the United States. Med Care 2006 Oct; 44 (10): 936-945
24. Hanlon JT, Handler S, Maher R, et al. Geriatric pharmacotherapy and polypharmacy. In: Fillit H, Rockwood K, Woodhouse K, editors. Brocklehurst's textbook of geriatric medicine. 7th ed. London: Churchill Livingstone, 2010: 880-5
25. Lipton H, Bero L, Bird J, et al. Undermedication among geriatric outpatients: Results of a randomized controlled trial. Ann Rev Gerontol 1992; 12: 95-108
26. Ahmed A, Allman RM, DeLong JF, et al. Age-related underutilization of angiotensin-converting enzyme inhibitors in older hospitalized heart failure patients. South Med J 2002 Jul; 95 (7): 703-710
27. Gambassi G, Lapane KL, Sgadari A, et al. Effects of angiotensin- converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology. Arch Intern Med 2000 Jan 10; 160 (1): 53-60
28. Howard PA, Shireman TI, Dhingra A, et al. Patterns of ACE inhibitor use in elderly Medicaid patients with heart failure. Am J Geriatr Cardiol 2002 Sep-Oct; 11 (5): 287-294
29. Masoudi FA, Rathore SS, Wang Y, et al. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction. Circulation 2004 Aug 10; 110 (6): 724-731
30. Mendelson G, Aronow WS. Underutilization of angiotensinconverting enzyme inhibitors in older patients with Q-wave anterior myocardial infarction in an academic hospital-based geriatrics practice. J Am Geriatr Soc 1998 Jun; 46 (6): 751-2
31. Allsworth JE, Toppa R, Palin NC, et al. Racial and ethnic disparities in the pharmacologic management of diabetes mellitus among long-term care facility residents. Ethn Dis 2005 Spring; 15 (2): 205-212
32. Dunn EJ, Burton CJ, Feest TG. The care of patients with diabetic nephropathy: Audit, feedback, and improvement. QJM 1999 Aug; 92 (8): 443-9
33. Hollingworth SA, Byrne GJ. Prescribing trends in cognition enhancing drugs in Australia. Int Psychogeriatr 2011 Mar; 23 (2): 238-245
34. Brown MN, Lapane KL, Luisi AF. The management of depression in older nursing home residents. J Am Geriatr Soc 2002 Jan; 50 (1): 69-76
35. George K, Davison TE, McCabe M, et al. Treatment of depression in low-level residential care facilities for the elderly. Int Psychogeriatr 2007 Dec; 19 (6): 1153-1160
36. Parikh S, Mogun H, Avorn J, et al. Osteoporosis medication use in nursing home patients with fractures in 1US state. Arch Intern Med 2008 May 26; 168 (10): 1111-5
37. Bernabei R, Gambassi G, Lapane K, et al. Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology. JAMA 1998 Jun 17; 279 (23): 1877-1882
38. Feldt KS, Gunderson J. Treatment of pain for older hip fracture patients across settings. Orthop Nurs 2002 Sep-Oct; 21 (5): 63-4, 6-71
39. Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment): Consensus validation. Int J Clin Pharmacol Ther 2008 Feb; 46 (2): 72-83
40. Winkelmayer WC, Fischer MA, Schneeweiss S, et al. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes. Am J Kidney Dis 2005 Dec; 46 (6): 1080-7
41. Steinman MA, Landefeld CS, Rosenthal GE, et al. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 2006 Oct; 54 (10): 1516-1523
42. Deplanque D, Leys D, Parnetti L, et al. Stroke prevention and atrial fibrillation: Reasons leading to an inappropriate management. Main results of the SAFE II study. Br J Clin Pharmacol 2004 Jun; 57 (6): 798-806
43. Wright RM, Sloane R, Pieper CF, et al. Underuse of indicated medications among physically frail older US veterans at the time of hospital discharge: Results of a cross-sectional analysis of data from the Geriatric Evaluation and Management Drug Study. Am J Geriatr Pharmacother 2009 Oct; 7 (5): 271-280
44. Marcucci M, Iorio A, Nobili A, et al. Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards. Eur J InternMed 2010 Dec; 21 (6): 516-523
45. Lang PO, Hasso Y, DrameM, et al. Potentially inappropriate prescribing including under-use amongst older patients with cognitive or psychiatric co-morbidities. Age Ageing 2010 May; 39 (3): 373-381
46. Coveney AP, O'Brien GC, Fulton GJ. ACE up the sleeveare vascular patients medically optimized? Vasc Health Risk Manag 2011; 7: 15-21
47. Gallagher P, Lang PO, Cherubini A, et al. Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. Eur J Clin Pharmacol 2011 Nov; 67 (11): 1175-1188
48. Heston LL, Garrard J, Makris L, et al. Inadequate treatment of depressed nursing home elderly. J Am Geriatr Soc 1992 Nov; 40 (11): 1117-1122
49. Lapane KL, Barbour MM, Van Haaren A, et al. Antiischemic therapy in patients with coronary heart disease living in long-termcare. Systematic Assessment ofGeriatric Drug Use by Epidemiology (SAGE) Group. Pharmacotherapy 1999May; 19 (5): 627-634
50. Lapane KL, Fernandez HH, Friedman JH. Prevalence, clinical characteristics, and pharmacologic treatment of Parkinson's disease in residents in long-term care facilities. SAGE Study Group. Pharmacotherapy 1999 Nov; 19 (11): 1321-7
51. Spooner JJ, Lapane KL, Hume AL, et al. Pharmacologic treatment of diabetes in long-term care. J Clin Epidemiol 2001 May; 54 (5): 525-530
52. Christian JB, Lapane KL, Toppa RS. Racial disparities in receipt of secondary stroke prevention agents among US nursing home residents. Stroke 2003 Nov; 34 (11): 2693-7
53. Sloane PD, Gruber-Baldini AL, Zimmerman S, et al. Medication undertreatment in assisted living settings. Arch Intern Med 2004 Oct 11; 164 (18): 2031-7
54. Hughes CM, Lapane KL. Factors associated with the initiation and discontinuation of secondary stroke prevention agents in nursing homes. J Stroke Cerebrovasc Dis 2004 Jul-Aug; 13 (4): 164-170
55. Hanlon JT, Wang X, Castle NG, et al. Potential underuse, overuse, and inappropriate use of antidepressants in older veteran nursing home residents. J Am Geriatr Soc 2011 Aug; 59 (8): 1412-1420
56. Hayward RA, Asch SM, Hogan MM, et al. Sins of omission: Getting too little medical care may be the greatest threat to patient safety. J Gen Intern Med 2005 Aug; 20 (8): 686-691
57. Fahey T, Montgomery AA, Barnes J, et al. Quality of care for elderly residents in nursing homes and elderly people living at home: Controlled observational study. BMJ 2003 Mar 15; 326 (7389): 580
58. Soumerai SB, McLaughlin TJ, Spiegelman D, et al. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA 1997 Jan 8; 277 (2): 115-121
59. Ko DT, Mamdani M, Alter DA. Lipid-lowering therapy with statins in high-risk elderly patients: The treatmentrisk paradox. JAMA 2004 Apr 21; 291 (15): 1864-1870
60. Flaker GC, McGowan DJ, Boechler M, et al. Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation. Am Heart J 1999 Feb; 137 (2): 307-312
61. Lau E, Bungard TJ, Tsuyuki RT. Stroke prophylaxis in institutionalized elderly patients with atrial fibrillation. J Am Geriatr Soc 2004 Mar; 52 (3): 428-433
62. Brass LM, Krumholz HM, Scinto JD, et al. Warfarin use following ischemic stroke among Medicare patients with atrial fibrillation. Arch Intern Med 1998 Oct 26; 158 (19): 2093-2100
63. Andrade SE, Majumdar SR, Chan KA, et al. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med 2003 Sep 22; 163 (17): 2052-7
64. Feldstein A, Elmer PJ, Orwoll E, et al. Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: A gap in evidence-based practice guideline implementation. Arch Intern Med 2003 Oct 13; 163 (18): 2165-2172
65. Ryan C, O'Mahony D, Kennedy J, et al. Potentially inappropriate prescribing in an Irish elderly population in primary care. Br J Clin Pharmacol 2009 Dec; 68 (6): 936-947
66. Barry PJ, Gallagher P, Ryan C, et al. START (screening tool to alert doctors to the right treatment): An evidencebased screening tool to detect prescribing omissions in elderly patients. Age Ageing 2007 Nov; 36 (6): 632-8
67. Parsons C, Lapane K, Kerse N, et al. Prescribing for older people in nursing homes: A review of the key issues. Int J Older People Nurs 2011 Mar; 6 (1): 45-54
68. Ruths S, Straand J, Nygaard HA. Multidisciplinary medication review in nursing home residents: What are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) Study. Qual Saf Health Care 2003 Jun; 12 (3): 176-180
69. Tjia J, Rothman MR, Kiely DK, et al. Daily medication use in nursing home residents with advanced dementia. J Am Geriatr Soc 2010 May; 58 (5): 880-8
70. Holmes HM. Rational prescribing for patients with a reduced life expectancy. Clin Pharmacol Ther 2009 Jan; 85 (1): 103-7
71. Holmes HM, Hayley DC, Alexander GC, et al. Reconsidering medication appropriateness for patients late in life. Arch Intern Med 2006 Mar 27; 166 (6): 605-9
72. Van Spall HG, Toren A, Kiss A, et al. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: A systematic sampling review. JAMA 2007 Mar 21; 297 (11): 1233-1240
73. Martin K, Begaud B, Latry P, et al. Differences between clinical trials and postmarketing use. Br J Clin Pharmacol 2004 Jan; 57 (1): 86-92
74. Pedone C, Lapane KL. Generalizability of guidelines and physicians' adherence: Case study on the Sixth Joint National Committee's guidelines on hypertension. BMC Public Health 2003 Jul 21; 3: 24
75. Agarwal G, Nair K, Cosby J, et al. GPs' approach to insulin prescribing in older patients: A qualitative study. Br J Gen Pract 2008 Aug; 58 (553): 569-575
76. Fernando P, Crome P. Combating age discrimination: A United kingdom perspective. EGM 2011; 2: 263-9
77. Barakat K, Wilkinson P, Deaner A, et al. How should age affect management of acute myocardial infarction? A prospective cohort study. Lancet 1999 Mar 20; 353 (9157): 955-9
78. Zaidi AM, Fitzpatrick AP, Keenan DJ, et al. Good outcomes from cardiac surgery in the over 70s. Heart 1999 Aug; 82 (2): 134-7
79. Conaway DG, House J, Bandt K, et al. The elderly: Health status benefits and recovery of function one year after coronary artery bypass surgery. J Am Coll Cardiol 2003 Oct 15; 42 (8): 1421-6
80. Harries C, Forrest D, Harvey N, et al. Which doctors are influenced by a patient's age? A multi-method study of angina treatment in general practice, cardiology and gerontology. Qual Saf Health Care 2007 Feb; 16 (1): 23-27
81. Zimmer AW, Calkins E, Hadley E, et al. Conducting clinical research in geriatric populations. Ann Intern Med 1985 Aug; 103 (2): 276-283
82. Carbonin P, PahorM, BernabeiR, et al. Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc 1991 Nov; 39 (11): 1093-9
83. Gurwitz JH, Field TS, Avorn J, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000 Aug 1; 109 (2): 87-94
84. Zopf Y, Rabe C, Neubert A, et al. Women encounter ADRs more often than do men. Eur J Clin Pharmacol 2008 Oct; 64 (10): 999-1004
85. Pedone C, Corsonello A, Carosella L, et al. Comparison of digitalis-related adverse events in hospitalized men and women in Italy: An observational study. Clin Ther 2005 Dec; 27 (12): 1922-9
86. Rahimi AR, Spertus JA, Reid KJ, et al. Financial barriers to health care and outcomes after acute myocardial infarction. JAMA 2007 Mar 14; 297 (10): 1063-1072
87. Choudhry NK, Patrick AR, Antman EM, et al. Costeffectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries. Circulation 2008 Mar 11; 117 (10): 1261-8
88. Heisler M, Choi H, Rosen AB, et al. Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: A longitudinal analysis. Med Care Feb; 2010; 48 (2): 87-94
89. Reuben DB. Medical care for the final years of life: ''When you're 83, it's not going to be 20 years''. JAMA 2009 Dec 23; 302 (24): 2686-2694
90. Steinman MA, Hanlon JT. Managing medications in clinically complex elders: ''There's got to be a happy medium''. JAMA 2010 Oct 13; 304 (14): 1592-1601
91. Landi F, Onder G, Cesari M, et al. Pain management in frail, community-living elderly patients. Arch Intern Med 2001 Dec 10-24; 161 (22): 2721-4
92. Won A, Lapane K, Gambassi G, et al. Correlates and management of nonmalignant pain in the nursing home. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology. J Am Geriatr Soc 1999 Aug; 47 (8): 936-942
93. Smalbrugge M, Jongenelis LK, Pot AM, et al. Pain among nursing home patients in the Netherlands: Prevalence, course, clinical correlates, recognition and analgesic treatment: An observational cohort study. BMC Geriatr 2007; 7: 3
94. Gladstone DJ, Bui E, Fang J, et al. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke 2009 Jan; 40 (1): 235-240
95. Pisters R, Van Oostenbrugge RJ, Knottnerus IL, et al. The likelihood of decreasing strokes in atrial fibrillation patients by strict application of guidelines. Europace 2010 Jun; 12 (6): 779-784
96. Beer C, Hyde Z, Almeida OP, et al. Quality use of medicines and health outcomes among a cohort of community dwelling older men: An observational study. Br J Clin Pharmacol 2011 Apr; 71 (4): 592-9
97. Schmader KE, Hanlon JT, Pieper CF, et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 2004 Mar 15; 116 (6): 394-401
98. Spinewine A, Swine C, Dhillon S, et al. Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: A randomized, controlled trial. J Am Geriatr Soc 2007 May; 55 (5): 658-665
99. Tulner LR, Van Campen JP, Frankfort SV, et al. Changes in under-treatment after comprehensive geriatric assessment: An observational study. Drugs Aging 2010 Oct 1; 27 (10): 831-843
100. Bajorek BV, Krass I, Ogle SJ, et al. Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: A pharmacist-led multidisciplinary intervention. J Am Geriatr Soc 2005 Nov; 53 (11): 1912-1920
101. Lipton HL, Bero LA, Bird JA, et al. The impact of clinical pharmacists' consultations on physicians' geriatric drug prescribing: A randomized controlled trial. Med Care 1992 Jul; 30 (7): 646-658
102. Krska J, Cromarty JA, Arris F, et al. Pharmacist-led medication review in patients over 65: A randomized, controlled trial in primary care. Age Ageing 2001 May; 30 (3): 205-211
103. Zermansky AG, Alldred DP, Petty DR, et al. Clinical medication review by a pharmacist of elderly people living in care homes: Randomised controlled trial. Age Ageing 2006 Nov; 35 (6): 586-591
104. Altavela JL, Jones MK, Ritter M. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system. J Manag Care Pharm 2008 Nov-Dec; 14 (9): 831-843
105. Majumdar SR, Beaupre LA, Harley CH, et al. Use of a case manager to improve osteoporosis treatment after hip fracture: Results of a randomized controlled trial. Arch Intern Med 2007 Oct 22; 167 (19): 2110-5
106. Feldstein A, Elmer PJ, Smith DH, et al. Electronic medical record reminder improves osteoporosis management after a fracture: A randomized, controlled trial. J Am Geriatr Soc 2006 Mar; 54 (3): 450-7
107. Davis JC, Guy P, Ashe MC, et al. HipWatch: Osteoporosis investigation and treatment after a hip fracture: A 6-month randomized controlled trial. J GerontolA Biol Sci Med Sci 2007 Aug; 62 (8): 888-891
108. Little EA, Eccles MP. A systematic review of the effectiveness of interventions to improve post-fracture investigation and management of patients at risk of osteoporosis. Implement Sci 2010; 5: 80
109. Jackson SL, Peterson GM, Vial JH. A community-based educational intervention to improve antithrombotic drug use in atrial fibrillation. Ann Pharmacother 2004 Nov; 38 (11): 1794-9
110. Gallagher PF, O'Connor MN, O'Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: A randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther Jun; 2011; 89 (6): 845-854